Overview

This trial is active, not recruiting.

Conditions surgery, trauma to the abdomen, acute respiratory failure
Treatments non invasive ventilation (facial mask and niv ventilator), standard oxygen therapy with facial mask
Sponsor University Hospital, Montpellier
Start date May 2013
End date December 2014
Trial size 300 participants
Trial identifier NCT01971892, UF 9015

Summary

Acute respiratory failure may occur early in the postoperative course, requiring endotracheal intubation and mechanical ventilation in selected patients, thus increasing morbidity and mortality and prolonging intensive care unit (ICU) and hospital stay.We will perform a multicenter, prospective, randomized clinical trial to compare the efficacy of non invasive ventilation (NIV) which associated pressure support ventilation (PSV: 5 to 15 cmH2O) and positive end expiratory pressure (PEEP: 5 to 10 cmH2O) with standard oxygen therapy in the treatment of postoperative acute respiratory failure. We also set out to examine the hypothesis that early application of NIV may prevent intubation and mechanical ventilation in patients who develop acute respiratory failure after abdominal surgery.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification safety/efficacy study
Intervention model parallel assignment
Masking open label
Primary purpose treatment
Arm
(Experimental)
Experimental arm = non invasive ventilation (NIV) which associated pressure support ventilation (PSV: 5 to 15 cmH2O) and positive end expiratory pressure (PEEP: 5 to 10 cmH2O) NIV will intermittently delivered to the patients for at least six hours (cumulative tme of all trials which lasted at least 30 min) during the first 24h after the initiation of treatment. Between each NIV period, the patient will received supplemental oxygen through facial mask to achieve an oxygen saturation level above 94%.
non invasive ventilation (facial mask and niv ventilator)
Non invasive ventilation (NIV) which associated pressure support ventilation (PSV: 5 to 15 cmH2O) and positive end expiratory pressure (PEEP: 5 to 10 cmH2O). NIW will be delivered through a facial mask with either NIV ventilator or ICU ventilator with NIV option
(Active Comparator)
Patients assigned to standard medical therapy will received supplemental oxygen via a facial Venturi mask at a rate of up to 15 liters per minute with in order to maintain peripheral oxygen saturation above 94%.
standard oxygen therapy with facial mask
facial Venturi mask

Primary Outcomes

Measure
The primary end point for the comparison between noninvasive ventilation (NIV) and standard oxygen therapy will be the tracheal intubation within 7 days after the initiation of treatment.
time frame: primary end point will be evaluated within 7 days after the initiation of treatment.

Secondary Outcomes

Measure
Gas exchange after one to two hours after inclusion in the protocol
time frame: one to two hours after inclusion in the protocol
nosocomial infections within the 14 days and mortality
time frame: At D-14 that means 14 days after initiation of treatment
length of ICU
time frame: From inclusion until the study until discharge or at 90 days maximal of ICU

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: Eligibility : - age of more than 18 years - scheduled for elective or not elective abdominal surgery requiring laparotomy or laparoscopy and general anesthesia. Inclusion : - acute respiratory failure occurring within the seven days of the surgery procedure which is defined as presence and persistence for at least 30 min and at least one of the two followings: 1) a respiratory rate of more than 30 breaths per minute and 2) clinical signs suggestive of respiratory muscle fatigue, increased work of breathing, or both, such as use of respiratory accessory muscles, paradoxical motion of the abdomen, or retraction of intercostal spaces - hypoxemia defined by a PaO2 lower than 60 mmHg in ambient air or lower than 80 mmHg under 15 liters O2 or an arterial O2 saturation by pulse-oximetry (SpO2) lower than 90% (PaO2/FiO2< 200 mmHg). Exclusion Criteria: - Emergency procedure surgery (operation that must be performed as soon as possible and no longer than 12 hours after inclusion in the study) - previous recruitment into another trial. - Cardiopulmonary arrest - Glasgow coma scale <8 - Absence of airway protective gag reflex - Upper airway obstruction - Pregnancy. - Patients who refuse to undergo endotracheal intubation, whatever the initial therapeutic approach - Chronic home non invasive ventilation

Additional Information

Official title Non Invasive Ventilation After Abdominal Surgery in Postoperative Acute Respiratory Failure: a Multicenter Randomized Controlled Trial.
Principal investigator Samir Jaber, MD PhD
Description The Non-Invasive Ventilation After Surgery (NIVAS) is an investigator-initiated, multi-center, stratified, two-arm parallel-group trial with a computer-generated allocation sequence and electronic system based randomization. The study protocol and statistical analysis plan were approved for all centers by a central Ethics Committee (France) according to French law.The NIVAS study is conducted in accordance with the declaration of Helsinki and was registered on August 2013.All centers have a long experience with NIV (more than 10 years of NIV use for ARF, and more than 5 years of NIV use for ARF following abdominal surgery). Randomization will stratified by department, age (less or more 60 years), site of surgery (upper or lower abdominal) and according to the presence or absence of postoperative epidural analgesia as this may influence outcomes. Treatment assignments will concealed from patients, research staff, the statistician, and the data monitoring and safety committee.
Trial information was received from ClinicalTrials.gov and was last updated in December 2014.
Information provided to ClinicalTrials.gov by University Hospital, Montpellier.